These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2580107)

  • 21. [Spontaneous variability of ventricular extrasystole in chronic Chagas cardiopathy].
    Grupi CJ; Sosa EA; De Carvalho JF; Antonelli RH; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1991 Jun; 56(6):445-50. PubMed ID: 1726676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
    Anderson JL; Harrison DC; Meffin PJ; Winkle RA
    Drugs; 1978 Apr; 15(4):271-309. PubMed ID: 648399
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of ethmozine to propranolol and the combination for ventricular arrhythmias.
    Butman SM; Knoll ML; Gardin JM
    Am J Cardiol; 1987 Sep; 60(7):603-7. PubMed ID: 2442994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic mexiletine therapy for suppression of ventricular arrhythmias.
    Duke M
    Clin Cardiol; 1988 Mar; 11(3):132-6. PubMed ID: 2451577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs and the heart. IV. Antiarrhythmic agents.
    Opie LH
    Lancet; 1980 Apr; 1(8173):861-8. PubMed ID: 6103220
    [No Abstract]   [Full Text] [Related]  

  • 26. Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.
    Pratt CM; Théroux P; Slymen D; Riordan-Bennett A; Morisette D; Galloway A; Seals AA; Hallstrom A
    Am J Cardiol; 1987 Feb; 59(4):278-83. PubMed ID: 2880497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent progress in analysis of arrhythmias using electrocardiography].
    Fujino T; Ishida S; Takahashi N; Nakagawa M; Ito M; Saikawa T
    Rinsho Byori; 1993 Apr; 41(4):426-32. PubMed ID: 7688834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spontaneous variability of ventricular arrhythmias in follow-up of anti-arrhythmia therapy].
    Schmidt G; Barthel P; Ulm K; Goedel-Meinen L; Baedeker W
    Herz; 1990 Feb; 15(1):11-20. PubMed ID: 1690167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs for treatment of ventricular arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ
    Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Days required for 75% suppression of ventricular premature contractions by antiarrhythmic agents obtained from continuous in-hospital ECG monitoring.
    Fujito T; Takayanagi K; Shimizu M; Inoue T; Hayashi T; Sakai Y; Morooka S; Takabatake Y
    Jpn Heart J; 1994 Mar; 35(2):125-40. PubMed ID: 7517462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
    Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP
    J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of antiarrhythmic drugs in prevention of sudden coronary death.
    Winkle RA
    Ann N Y Acad Sci; 1982; 382():247-57. PubMed ID: 6979282
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Kim SG; Mercando AD; Tam S; Fisher JD
    J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous ECG (Holter) recordings in the evaluation of antiarrhythmic drugs.
    Bleifer DJ; Hansmann DR; Bleifer SB; Sheppard JS; Karpman HL
    Schweiz Med Wochenschr; 1974 Nov; 104(44):1585-6. PubMed ID: 4138545
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
    Hashimoto K; Shibuya T; Satoh H; Imai S
    Jpn Circ J; 1983 Jan; 47(1):92-7. PubMed ID: 6827775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
    Lüderitz B; Manz M; Steinbeck G
    Dtsch Med Wochenschr; 1983 Nov; 108(44):1663-7. PubMed ID: 6414795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.